3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Not yet recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
Gynecologic
1
Genitourinary
1
Breast
1
Conditions
Anxiety Disorders
4
Neoplasms
2
Depression
2
Breast Neoplasms
2
Uterine Cervical Neoplasms
1
Testicular Germ Cell Tumor
1
Sarcoma
1
Pulmonary Disease, Chronic Obstructive
1
Ovarian Neoplasms
1
Lung Diseases, Interstitial
1
Leukemia, Myeloid, Acute
1
Head and Neck Neoplasms
1
Dyspnea
1
Interventions
Doxorubicin
27
pembrolizumab
24
Radiotherapy
20
Cyclophosphamide
18
Magnetic Resonance Spectroscopy
17
Specimen Handling
14
Nivolumab
14
Ifosfamide
13
Gemcitabine
13
Surgical Procedures, Operative
11
Biopsy
11
Radiation
10
Temozolomide
9
X-Rays
8
Ipilimumab
8
pazopanib
7
fludarabine
7
cabozantinib
7
Irinotecan
7
Blood Specimen Collection
7
tazemetostat
6
liposomal doxorubicin
6
Trabectedin
6
Surveys and Questionnaires
6
Phantoms, Imaging
6
olaparib
5
eribulin
5
atezolizumab
5
anlotinib
5
Vincristine
5
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Sarcoma
×
Hypnosis
×
1 year
×
Clear all
NCT07614620
2026-05-29
HYPNO-AJA2
Institut Bergonié
Phase NA
Not yet recruiting
70 enrolled